REENA MATTHEWS: Open Payments
NPI 1932665536 · MISSOURI CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,115 in 34 payments from 11 companies in 2025. Trend: 2023 $1,175 · 2024 $1,092 · 2025 $1,115
Food & beverage: $1,009Education: $106
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $210 |
| Syndax Pharmaceuticals, Inc. | 6 | $189 |
| Incyte Corporation | 5 | $144 |
| SOBI, INC | 4 | $139 |
| Astellas Pharma US Inc | 4 | $127 |
| AstraZeneca Pharmaceuticals LP | 3 | $98 |
| Celgene Corporation | 3 | $86 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| ABBVIE INC. | 1 | $33 |
| Rigel Pharmaceuticals, Inc. | 1 | $32 |
Products named: JAKAFI, Vonjo, JAYPIRCA, CALQUENCE, Cresemba, REBLOZYL, EPKINLY, Xospata.
Industry payments across TX — which companies pay providers there.
